Portfolio (Quarterly)
Guide ↗
Ishara Investments LP
· CIK 0002111609| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | PRAXIS PRECISION MEDICINES I | — | 22,550.0 | $7.3M | 6.88% | -17K | -43.6% | $322.19 | — |
| 2 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 41,000.0 | $6.9M | 6.56% | NEW | — | $169.02 | +36.4% |
| 3 | — PUT | PRAXIS PRECISION MEDICINES I | — | 20,500.0 | $6.6M | 6.25% | NEW | — | $322.19 | — |
| 4 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 1,025,000.0 | $5.9M | 5.63% | +225K | +28.1% | $5.80 | +2.1% |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 276,750.0 | $5.6M | 5.27% | NEW | — | $20.13 | +33.0% |
| 6 | FOLD | AMICUS THERAPEUTIC | Healthcare | 369,000.0 | $5.3M | 5.05% | +9K | +2.5% | $14.46 | +0.2% |
| 7 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 82,000.0 | $4.6M | 4.38% | -18K | -18.0% | $56.49 | -11.1% |
| 8 | — | VERASTEM INC | — | 820,000.0 | $4.3M | 4.12% | +550K | +203.7% | $5.30 | — |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 174,250.0 | $3.7M | 3.46% | +124K | +248.5% | $20.95 | +7.2% |
| 10 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 55,350.0 | $3.5M | 3.29% | NEW | — | $62.70 | +23.0% |
| 11 | PCVX | VAXCYTE INC | Healthcare | 57,400.0 | $3.3M | 3.16% | +7K | +14.8% | $58.11 | -16.1% |
| 12 | VERA | VERA THERAPEUTICS INC | Healthcare | 82,000.0 | $3.3M | 3.12% | NEW | — | $40.23 | -17.4% |
| 13 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 110,700.0 | $3.3M | 3.11% | NEW | — | $29.71 | +42.2% |
| 14 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 174,250.0 | $3.2M | 3.08% | NEW | — | $18.64 | -12.2% |
| 15 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 1,230,000.0 | $2.9M | 2.73% | -90K | -6.8% | $2.34 | +51.3% |
| 16 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 57,400.0 | $2.8M | 2.67% | NEW | — | $49.16 | -3.3% |
| 17 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 123,000.0 | $2.7M | 2.59% | -37K | -23.1% | $22.26 | -5.9% |
| 18 | ARDX | ARDELYX INC | Healthcare | 451,000.0 | $2.7M | 2.56% | NEW | — | $5.99 | +4.7% |
| 19 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 82,000.0 | $2.2M | 2.10% | NEW | — | $27.09 | -3.9% |
| 20 | GMAB | GENMAB A/S | Healthcare | 82,000.0 | $2.2M | 2.08% | +12K | +17.1% | $26.83 | -4.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%